Roche Holding AG (ROG.SW)

Exchange: Swiss Exchange
Currency: CHF

Price: 366.50 (Close)



52 Week range 200d Moving Avg. Beta
288.55 – 374.22 357.70 0.31
Dividend Dividend Yield Ex-Dividend date
9.30 2.54% 2022-03-17
P/E Ratio Latest EPS DGR 3 years
22.63 16.20 3.11%
Very low Volatility
Dividend Growth


Roche Holding AG diagnostics and pharmaceuticals businesses in Switzerland, Germany, and rest of Europe. It offers pharmaceutical products for anaemia, anticoagulation therapy, bone, cancer, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, HPV, infectious diseases, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid disorders, liver, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases. The company provides diagnostic solutions, such as blood gas analysis; blood screening; cancer screening/monitoring; cardiac markers; cardiovascular testing; cholesterol monitoring; coagulation monitoring; coagulation routine and specialty testing; data management; diabetes monitoring; diabetes therapy; electrolytes analysis; emergency medicine; hemostasis; heterogeneous immunochemistry; homogeneous immuno assays; immunology; infectious diseases; intensive care testing; monitoring anti platelet therapy; neonatal intensive care units; nucleic acid purification; PCR clinical diagnostics; physical fitness testing; platelet function testing; quality control service; real-time PCR diagnostic systems; serum work area; urinalysis; and workflow solutions. Roche Holding AG has a strategic alliance with Wisconsin Diagnostic Laboratories; and a collaboration agreement with Five Prime Therapeutics, Inc. The company was founded in 1896 and is headquartered in Basel, Switzerland.


Sector: Industry:
Healthcare Other

Environment, Social and Governance (ESG) Ratings

Total ESG Score

24 – 36 percentile


1 – 2 percentile


14 – 2 percentile


10 – 2 percentile

Controversy level



see MSCI ESG rating explained

Dividend Safety Metrics

Latest EPS 16.20
Annual Payout 9.30
Payout Ratio 57.41%
Dividend growth 33 Years
Dividend Score 76
Dividend Coverage Ratio 1.74
Altman-Z score 0.00


Roche Holding AG (ROG.SW) Valuation

Roche Holding AG current dividend yield of 2.54% is -14% below its 5-year average. The 5-year average dividend yield is 2.96% (see red-line in chart). This indicates the stock looks overvalued today.

Roche Holding AG (ROG.SW) Performance

The chart below displays the total price return(%) of Roche Holding AG for different periods:


Roche Holding AG (ROG.SW) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of Roche Holding AG for different periods:


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
2.54 9.30 57.41% 33 Years


Dividend Growth Summary

3 Year Growth Rate (CAGR) 3.11%
5 Year Growth Rate (CAGR) 2.36%
10 Year Growth Rate (CAGR) 3.26%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2022 9.300 -%
2021 9.100 1.1%
2020 9.000 3.4%
2019 8.700 4.8%
2018 8.300 1.2%
2017 8.200 1.2%
2016 8.100 1.3%
2015 8.000 2.6%
2014 7.800 6.1%
2013 7.350 8.1%
2012 6.800 3.0%
2011 6.600 10.0%
2010 6.000 20.0%
2009 5.000 8.7%
2008 4.600 35.3%

Roche Holding AG (ROG.SW) Dividend Payment History